• Oleanolic Acid: Unraveling iNOS and COX-2 Modulation in Next

  2026-06-18

  Explore the scientific foundation of oleanolic acid as an inducible nitric oxide synthase-inducing antiviral research compound. This article uniquely examines how its mechanism of action and solubility profile enable robust, reproducible immune modulation assays, bridging molecular pharmacology with advanced nanoliposome technologies.

• MEK1/2-ERK1/2 Pathway Drives Lung Hemorrhage in Lupus Mice

  2026-06-18

  This study demonstrates that activation of the MEK1/2-ERK1/2 signaling cascade is a central driver of diffuse alveolar hemorrhage (DAH) in a murine lupus model. Selective inhibition of MEK1/2 or ERK1/2 normalized endothelial injury and hemostatic imbalance, highlighting new mechanistic links and potential intervention points for severe lupus-associated lung injury.

• 8-Chloroadenosine: Mechanism-Driven Innovation in Translatio

  2026-06-17

  This thought-leadership article unpacks the mechanistic underpinnings and strategic applications of 8-Chloroadenosine as a nucleoside analog for transcriptional regulation and RNA metabolism studies. We synthesize recent NSCLC lncRNA research, position APExBIO’s reagent in the competitive landscape, and offer actionable guidance for translational researchers aiming to bridge molecular insight with therapeutic innovation.

• ALDH2 Activation Promotes Cardiomyocyte Proliferation in Hea

  2026-06-17

  This study demonstrates that activating ALDH2 in mice promotes cardiomyocyte proliferation and delays heart failure onset during ventricular pressure overload. These findings reveal a novel regenerative pathway for cardiac repair, highlighting ALDH2 as a promising target for cardiac ischemia research.

• Ciprofloxacin Modulates Ferroptosis via Mitochondrial Zinc P

  2026-06-16

  This study reveals a previously unrecognized mechanism by which ciprofloxacin amplifies RSL3-induced ferroptosis in cancer cells, acting through mitochondrial zinc accumulation and the STING1–CAV2 pathway. These findings provide a nuanced understanding of ferroptosis regulation and may inform targeted therapeutic strategies in oncology.

• Optimizing Cardiovascular Assays with Fosinopril Sodium (SKU

  2026-06-16

  This article delivers a scenario-driven, evidence-based guide for labs using Fosinopril sodium (SKU A4079) in cell viability, proliferation, and cytotoxicity assays. It addresses real bench challenges—such as ACE inhibitor solubility, reproducibility, and vendor reliability—highlighting how APExBIO's offering streamlines cardiovascular disease modeling with validated performance and transparent data.

• URB597 (KDS-4103): Precision FAAH Inhibition in Neuroresearc

  2026-06-15

  URB597, also known as KDS-4103, is a potent and selective FAAH inhibitor widely used for in vivo endocannabinoid signaling modulation. It elevates anandamide levels in the brain with high specificity, providing a robust tool for neuroplasticity and neuroinflammation research applications.

• CD98hc Orchestrates CNS Angiogenesis and Blood–Brain Barrier

  2026-06-15

  This study uncovers the central role of CD98hc in regulating angiogenesis and blood–brain barrier (BBB) integrity within the central nervous system (CNS). Through genetic mouse models and in vitro assays, the research demonstrates that CD98hc modulates the integrin–FAK pathway in a CNS-specific manner, revealing new therapeutic avenues for cerebrovascular disease.

• KU-55933: ATM Kinase Inhibitor Elevates DNA Damage Response

  2026-06-14

  KU-55933, a potent and selective ATM kinase inhibitor, enables researchers to dissect DNA damage response mechanisms and optimize cancer cell cycle arrest assays with precision. This article details advanced workflows, protocol enhancements, and troubleshooting tips, uniquely translating recent mitochondrial-DNA crosstalk insights into actionable experimental strategies.

• Cy3 Rabbit Anti-Goat IgG (H+L) Antibody: Technical Use Guide

  2026-06-13

  The Cy3 Rabbit Anti-Goat IgG (H+L) Antibody addresses the need for sensitive, specific detection of goat primary antibodies in fluorescence-based immunodetection workflows. It should be used exclusively with goat primaries in validated assays such as ICC/IF, IHC, flow cytometry, and ELISA, and is not suitable for detection of non-goat species or outside these modalities.

• MG-132 (Z-LLL-al): Precision Proteasome Inhibition in Cancer

  2026-06-12

  MG-132 (Z-LLL-al) provides researchers with nanomolar-level control over proteasome inhibition, enabling mechanistically precise apoptosis and cell cycle arrest studies. This guide delivers actionable protocols, troubleshooting strategies, and evidence-based insights—anchored in landmark research—to maximize the impact of MG-132 across cancer and oxidative stress workflows.

• Endothelial Endoglin Drives Astrocyte Reactivity in Alzheime

  2026-06-12

  Zhang et al. reveal that endothelium-specific Endoglin (ENG) is transmitted via cerebrovascular endothelial extracellular vesicles (CEEVs) to astrocytes, where it activates the TGFBRI/Smad3 pathway and promotes neuroinflammation in Alzheimer’s disease. This mechanistic insight reframes how vascular dysfunction contributes to AD pathogenesis and highlights ENG as a potential therapeutic target.

• Honokiol in Precision Immunometabolism: Beyond NF-κB Inhibit

  2026-06-11

  Explore Honokiol’s advanced utility as a small molecule immunometabolic modulator in cancer research. This article delivers a new perspective by connecting Honokiol’s mechanistic actions—including NF-κB pathway inhibition and ROS scavenging—to the latest discoveries in T cell metabolic flexibility.

• Verapamil HCl: Applied Workflows for Calcium Channel Blockad

  2026-06-11

  Verapamil HCl is redefining translational research with precise L-type calcium channel blockade, powering advanced models of apoptosis, inflammation, and osteoporosis. Discover applied workflows, troubleshooting insights, and new data-driven strategies for maximizing experimental impact using APExBIO’s high-purity Verapamil HCl.

• Telmisartan: Targeting Cardiac Hypertrophy Beyond AT1R Block

  2026-06-10

  This thought-leadership article explores Telmisartan’s mechanistic potential in translational cardiovascular research, with a focus on angiotensin II-driven cardiac hypertrophy, signaling crosstalk, and comparative strategies. It contextualizes Telmisartan’s value within evolving pathways such as JAK2/STAT3 and NF-κB, bridging current findings with the next generation of translational protocols and discovery platforms.

449 records 14/30 page Previous Next First page 上5页 1112131415 下5页 Last page